AX-DEMO-8Xv1
Demo Peptide B (Semaglutide 5 mg) · Lot DEMO-8X-001 · Axiom Public Demo
CRYPTOGRAPHICALLY SEALED
SHA-384: 358c7cd47666647c
Scan to verify
PRODUCT ATTRIBUTION
Axiom Public Demo
Brand identity verified
Submitted by: Axiom Public Demo

Originated by Axiom Public Demo, which attests it authorized this test as the brand of record.

Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.

Open / Print PDF
SAMPLE & VIAL VALIDATION
Validated vial
Vial as received & analyzed
BrandAxiom Public Demo
ProductDemo Peptide B (Semaglutide 5 mg)
Lot / BatchDEMO-8X-001
Label ClaimDemo
Matrixlyophilized powder
Sample Count1
Seal IntactYes
Conditionsealed, intact
// LAYER 1: LC-MS/MS (ESI+)

Molecular Mass Fingerprinting

pass· validated in house
Identity confirmed
Semaglutide
THEORETICAL
4113.58 Da
OBSERVED
4113.63 Da
ERROR
0.05 Da
MASS SPECTRUM (ESI+)
1007550250theor. 4113.58obs. 4113.631029.4823.7m/zRelative abundance (%)
m/zINTENSITYCHARGE
1029.39100.0+4
823.7262.0+5

Observed mass matches Semaglutide within tolerance.

REVIEW & DIGITAL SIGNATURES
Analyst
Alana Reeves
ed25519:e5c84d55b3b850fbef24e8cc...
Technical Reviewer
Michael Niles
ed25519:09dceb5193cd72baa5e29372...
Laboratory Director
Daniel Brennan
ed25519:983246e73b753805daecabe9...
Released Jun 28, 2026, 02:25 UTC
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-DEMO-8X
RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.